These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 990138)

  • 21. [Hepatitis B immunoprophylaxis; vaccination of newborn infants].
    Mazel JA; Schalm SW; Ypma TD
    Ned Tijdschr Geneeskd; 1984 Aug; 128(34):1620-2. PubMed ID: 6483034
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serologic markers for hepatitis B virus in a group of healthy individuals (author's transl)].
    Vargas V; Pedreira JD; Esteban R; Hernández JM; Piqueras J; Guardia J
    Med Clin (Barc); 1982 Apr; 78(7):265-7. PubMed ID: 7087592
    [No Abstract]   [Full Text] [Related]  

  • 23. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 24. [Viral hepatitis B vaccine].
    Leone G; Melino G
    Clin Ter; 1983 Mar; 104(6):483-93. PubMed ID: 6851450
    [No Abstract]   [Full Text] [Related]  

  • 25. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the fully automated Cobas Core enzyme immunoassay for the quantitation of antibodies against hepatitis B virus surface antigen.
    Doche C; Thomé M; Dimet I; Bienvenu J
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):365-8. PubMed ID: 8704055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Active and passive immunization against hepatitis B virus infection].
    Colak H
    Mikrobiyol Bul; 1982 Jan; 16(1):71-6. PubMed ID: 7144619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis B vaccines. An evaluation of human plasma extracted vaccines].
    Prince AM; Vnek J
    Fortschr Med; 1982 Oct; 100(40):1839-43. PubMed ID: 6293948
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vaccination. Hepatitis B].
    Braun R; Kimmig P; Hassler D
    Dtsch Med Wochenschr; 2002 May; 127(20):1062. PubMed ID: 12051190
    [No Abstract]   [Full Text] [Related]  

  • 30. Different antibody responses against hepatitis B surface antigen among mouse strains transfected with mutant viral DNA.
    Hasegawa K; Joh R; Iizuka A; Naritomi T; Kanai N; Ogawa M; Torii N; Hayashi N
    J Gastroenterol; 2002; 37(12):1035-41. PubMed ID: 12522535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early prognostic significance of hepatitis B surface antigen specific circulating immune complexes in acute type B viral hepatitis].
    Markus R
    Z Gesamte Inn Med; 1990 Oct; 45(20):623-5. PubMed ID: 2099582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of viral hepatitis B in early infancy--hepatitis B vaccine (HBVac)].
    Tanabe M; Noguchi H; Tsuzuki K; Minowa S; Tsuyuki M; Tsuji A; Itoh S; Kanoh H; Katoh T; Mizokami M
    Nagoya J Med Sci; 1984 Mar; 46(1-4):49-54. PubMed ID: 6234469
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis.
    McGory R; Ishitani M; Oliveira W; Stevenson W; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1687-8. PubMed ID: 8658840
    [No Abstract]   [Full Text] [Related]  

  • 34. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
    Theilmann L; Goeser T
    Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyper-immunoglobulin-prophylaxis and follow-up in vertical hepatitis B (author's transl)].
    Joosten R; Feist D; Stürner KH
    Monatsschr Kinderheilkd; 1980 Aug; 128(8):537-9. PubMed ID: 6107832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immune response to the vaccine (Hepavax B) against the B virus].
    Pérez V; Fay O
    Acta Gastroenterol Latinoam; 1983; 13(4):675-82. PubMed ID: 6680259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Possibilities of eradicating the persistent HBsAg carrier state].
    Farber NA; Ambrozaĭtis AK; Kelli EI; Vygodskiĭ VS; Savitskiĭ GI
    Ter Arkh; 1984; 56(11):99-103. PubMed ID: 6523400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune globulins for protection against viral hepatitis.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Sep; 30(34):423-8, 433-5. PubMed ID: 6792483
    [No Abstract]   [Full Text] [Related]  

  • 39. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 40. Recommendations for protection against viral hepatitis.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(22):313-24, 329-35. PubMed ID: 3923311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.